Skip to main navigation Skip to search Skip to main content

Simulating Progression-Free and Overall Survival for First-Line Doublet Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients Based on Real-World Registry Data

  • Koen Degeling
  • , Hui-Li Wong
  • , Hendrik Koffijberg
  • , Azim Jalali
  • , Jeremy Shapiro
  • , Suzanne Kosmider
  • , Rachel Wong
  • , Belinda Lee
  • , Matthew Burge
  • , Jeanne Tie
  • , Desmond Yip
  • , Louise Nott
  • , Adnan Khattak
  • , Stephanie Lim
  • , Susan Caird
  • , Peter Gibbs
  • , Maarten IJzerman

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Simulating Progression-Free and Overall Survival for First-Line Doublet Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients Based on Real-World Registry Data'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology